BioCryst Pharmaceuticals | Ativos





Ativos Alterar Data
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
Chugai Pharma JPY 2.47T 285.01B 2025-12
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
DBV Technologies USD 110.49M 32.93M 2025-09
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Novavax USD 1.18B 156.66M 2025-09
PTC Therapeutics USD 2.9B 255.07M 2025-12
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12


BioCryst Pharmaceuticals Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.